← Every applicant
Dr Reddys Labs SA FDA Approvals
15 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| ZIMRIXBYNew drugJul 31, 2026INJECTION |
| HABITROLNew drugJul 17, 2025TROCHE/LOZENGE, ORAL |
| PHENTERMINE HYDROCHLORIDE AND TOPIRAMATENew drugJun 12, 2025CAPSULE, EXTENDED RELEASE, ORAL |
| PHENYLEPHRINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDENew drugMay 30, 2025SOLUTION, INTRAVENOUS |
| PROCHLORPERAZINE MALEATENew drugMay 19, 2025TABLET, ORAL |
| METYROSINENew drugApr 9, 2025CAPSULE, ORAL |
| BRIMONIDINE TARTRATENew drugFeb 16, 2024SOLUTION/DROPS, OPHTHALMIC |
| SAXAGLIPTIN AND METFORMIN HYDROCHLORIDENew drugAug 9, 2023TABLET, EXTENDED RELEASE, ORAL |
| FENTANYL CITRATENew drugAug 22, 2022TABLET, BUCCAL, SUBLINGUAL |
| HALOETTENew drugAug 5, 2022RING, VAGINAL |
| DILTIAZEM HYDROCHLORIDENew drugMay 5, 2022CAPSULE, EXTENDED RELEASE, ORAL |
| NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATENew drugApr 28, 2022CAPSULE, ORAL |
| MORPHINE SULFATENew drugJan 12, 2022TABLET, ORAL |
| VERARINGNew drugDec 9, 2021RING, VAGINAL |
| REZIPRESNew drugJun 14, 2021SOLUTION, INTRAVENOUS |